ArticleJAMA oncology2020

Need for More Comprehensive Evaluation of Immune-Related Adverse Events in Immunotherapy for Biliary Tract Cancer.

Dongxu Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.